Lucie Jetté, PhD
Biography & Research Background
Lucie Jetté, PhD, was a lead researcher at ConjuChem Biotechnologies Inc. (Montreal, Canada), the company that developed the CJC-1295 peptide class. She and her team synthesized the tetrasubstituted growth hormone-releasing hormone (GHRH) analog known as Modified GRF (1-29), which serves as the core peptide for both CJC-1295 (no DAC) and CJC-1295 (with DAC). Her foundational 2005 paper in Endocrinology described the structural modifications (tetrasubstitution at positions 2, 8, 15, and 27) that grant the peptide resistance to DPP-4 enzymatic degradation, and characterized the Drug Affinity Complex (DAC) albumin-binding mechanism designed to extend the peptide's half-life. This work established the pharmacological foundation for all subsequent CJC-1295 research, including the clinical trials conducted by Teichman et al. (2006). Her key publication is "Human Growth Hormone-Releasing Factor (hGRF)1-29-Albumin Bioconjugates Activate the GRF Receptor on the Anterior Pituitary in Rats: Identification of CJC-1295 as a Long-Lasting GRF Analog" (2005, Endocrinology). Lucie Jetté is being referenced as one of the leading scientists involved in CJC-1295 (no DAC) research. In no way is this doctor/scientist endorsing or advocating the purchase, sale, or use of this product for any reason. There is no affiliation or relationship, implied or otherwise, between Pure US Peptide and this doctor.
External Profiles
Authored Research Profiles (1)
Lucie Jetté, PhD is referenced as a leading researcher in the following peptide research profiles on Pure U.S. Peptides:
Lucie Jetté, PhD is being referenced as one of the leading scientists involved in the research and development of the peptides listed above. In no way is this doctor/scientist endorsing or advocating the purchase, sale, or use of any product for any reason. There is no affiliation or relationship, implied or otherwise, between Pure U.S. Peptides and this researcher. The purpose of citing the researcher is to acknowledge, recognize, and credit the exhaustive research and development efforts conducted by the scientists studying these peptides.